88IV - PR Newswire Asia's news - Health Care/Hospital


Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy First clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA) can safely upregulate an endogenous target protein in human skeletal muscle in a monogenic disease. Paired ... 2026-10-03T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene to Present Latest Preclinical Results of Novel Cos-TCE Platform in Rapid Oral Abstract Presentation at SITC 2026 SHANGHAI and HONG KONG , Oct. 3, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to ... 2026-10-03T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference STUART, Fla. , Oct. 2, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company ("Health In Tech" or the "Company"), today announced that ... 2026-10-02T Banking/Financial Service Health Care/Hospital
Chiron Medical Group's October "Safeguarding Breast Health With Heart" Campaign: Integrating Breast Health into Daily Life "Safeguarding Breast Health With Heart" ... 2026-10-02T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Ascletis' ASC36_35FDC Demonstrated Potential for Once-Monthly to Once-Quarterly Dosing and Robust Weight-Loss in Preclinical Studies Presented at EASD 2026 HONG KONG , Oct. 2, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announced the presentation of key preclinical data for its ASC36_35FDC (ASC36_35 co-formulation) ... 2026-10-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026 Late-breaking Phase III MASCOT oral presentation will characterize the clinical profile and diversity of participants in Lundbeck's ongoing global Phase III trial investigating amlenetug in multiple system ... 2026-10-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs Includes worldwide license to ABO2203, Abogen's mRNA-encoded CD19xCD3 T-Cell Engager ... 2026-10-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
I Peace Selected as a TOP 10 Awardee for the "Top 10 Longevity Breakthrough Awards 2026" PALO ALTO, Calif. , Oct. 2, 2026 /PRNewswire/ -- I Peace Inc., a biotech company pioneering induced pluripotent stem cell (iPS cell ) technologies for regenerative medicine and longevity, today announced ... 2026-10-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ENA Members Choose Vanessa Gorman as 2027 President-elect Secretary/treasurer, two board members also picked in annual election ... 2026-10-02T Education Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Momcozy Announces $100,000 Scholarship Fund to Expand Access to Perinatal Mental Health Certification LOS ANGELES , Oct. 2, 2026 /PRNewswire/ -- Momcozy, a leading global brand supporting women and families through pregnancy and motherhood, has partnered with Postpartum Support International (PSI) to establish ... 2026-10-02T Education Health Care/Hospital

PR Newswire Asia's news > Health Care/Hospital